dopaminergic receptor agonist
Jump to navigation
Jump to search
Adverse effects
- anorexia
- nausea/vomiting
- dizziness
- dyskinesia
- usually choreiform movements
- effect is dose dependent
- generally occurs after prolonged therapy
- psychosis
- impulse control disorders[4][5]
- compulsive behavior
- punding[3]
- gambling, shopping, hypersexuality[3]
- dementia
- depression
- sedation[3]
- excessive daytime sleepiness & sleep attacks[2]
- drug adverse effects of adrenergic receptor agonists
- drug adverse effects of dopaminergic receptor agonists
- drug adverse effects of sympathomimetic(s)
Drug interactions
- dopaminergic receptor agonists can induce psychosis in patients taking antipsychotics
More general terms
More specific terms
- apomorphine (Apokyn, Uprima)
- bromocriptine (Parlodel, Cycloset)
- cabergoline (Dostinex)
- fenoldopam (Corlopam)
- lisuride (Cuvalit, Lysenyl, Eunal)
- pergolide (Permax, pergolidum)
- piribedil (Trivastal)
- pramipexole (Mirapex)
- ropinirole (Requip, Requip-XL)
- rotigotine (Neupro)
Additional terms
References
- ↑ Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 1051
- ↑ 2.0 2.1 Prescriber's Letter 9(3):17 2002
- ↑ 3.0 3.1 3.2 3.3 Medical Knowledge Self Assessment Program (MKSAP) 16 American College of Physicians, Philadelphia 2012
Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022 - ↑ 4.0 4.1 Moore TJ et al Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs. JAMA Intern Med. Published online October 20, 2014. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25329919 <Internet> http://archinte.jamanetwork.com/article.aspx?articleid=1916909
Gagne JJ Finding Meaningful Patterns in Adverse Drug Event Reports. JAMA Intern Med. Published online October 20, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25329621 <Internet> http://archinte.jamanetwork.com/article.aspx?articleid=1916906
Weiss HD, Pontone GM Dopamine Receptor Agonist Drugs and Impulse Control Disorders. JAMA Intern Med. Published online October 20, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25329734 <Internet> http://archinte.jamanetwork.com/article.aspx?articleid=1916907 - ↑ 5.0 5.1 Corvol JC, Artaud F, Cormier-Dequaire F et al. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology. 2018 Jul 17;91(3):e189-e201. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29925549 <Internet> http://n.neurology.org/content/91/3/e189